title: Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans.
abstract: The diagnosis of erythema migrans (EM) is not always easy, and reports of culture- or PCR-confirmed diagnosis as well as reports of EM with simultaneous disseminated disease are few. Characteristics and incidence of EM in addition to frequency of early dissemination of B. burgdorferi were studied in the archipelago of South-Western Finland prospectively using questionnaires, skin biopsies and blood samples. Clinical EM was recognized in 82 patients (incidence 148/100,000 inhabitants/year). Of skin biopsy samples, 35.5% were positive by PCR (the majority B. garinii), and 21.5% by cultivation (all B. garinii). Of blood samples, 3.8% were positive by PCR, and 7.7% by cultivation. Of the patients, 30.9% were seropositive at the first visit, and 52.9% 3 weeks later. Of the patients with laboratory confirmed diagnosis, the EM lesion was ring-like in 31.8% and homogeneous in 65.9%. Dissemination of B. burgdorferi, based on culture or PCR positivity of blood samples, was detected in 11.0% of the patients. The frequency of generalized symptoms was nearly the same in patients with as in those without dissemination (22.2% vs 27.4%). Only 21.4% of the patients with culture-positive EM recalled a previous tick bite at the site of the EM lesion. We conclude that EM lesions are more often homogeneous than ring-like. B. burgdorferi may disseminate early without generalized symptoms.
authors.affiliation: Department of Medicine, Turku University Central Hospital, Finland. jarmo.oksi@utu.fi
authors.forename: J
authors.initials: J
authors.lastname: Oksi
authors.forename: H
authors.initials: H
authors.lastname: Marttila
authors.forename: H
authors.initials: H
authors.lastname: Soini
authors.forename: H
authors.initials: H
authors.lastname: Aho
authors.forename: J
authors.initials: J
authors.lastname: Uksila
authors.forename: M K
authors.initials: MK
authors.lastname: Viljanen
mesh_terms: D000907:Antibodies, Bacterial / Q000097:blood; D025065:Borrelia burgdorferi / Q000302:isolation & purification*; D015748:Borrelia burgdorferi Group / Q000302:isolation & purification*; D015787:Erythema Chronicum Migrans / Q000382:microbiology* / Q000473:pathology; D005387:Finland / Q000453:epidemiology; D006801:Humans; D016133:Polymerase Chain Reaction; D012867:Skin / Q000382:microbiology / Q000473:pathology
chemical_list: D000907:Antibodies, Bacterial